US government parts with USPTO on gene patents
In a surprise move, the US Department of Justice (DOJ) has broken with the USPTO's view that isolated DNA sequences should be patent-eligible
The DOJ is one of a number of amici who have weighed in recently on Myriad Genetics' appeal in The Association of Molecular Pathology v Myriad Genetics - a case whose outcome could make it harder to patent certain types...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.